Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Elsworth

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Neuroscience|January 1, 1989
Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regionsJ D Elsworth, A Y Deutch, D E Redmond, et al.
Life Sciences|January 1, 1991
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestionP Jatlow, J D Elsworth, C W Bradberry, et al.
Experimental Brain Research|January 11, 1991
Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controlsJ R Taylor, J D Elsworth, R H Roth, et al.
Cell Transplantation|March 1, 1997
Metabolic energy capacity of dopaminergic grafts and the implanted striatum in parkinsonian nonhuman primates as visualized with cytochrome oxidase histochemistryT J Collier, D E Redmond, R H Roth, et al.
Progress in Brain Research|January 1, 1990
Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeysJ R Taylor, J D Elsworth, R H Roth, et al.
Psychopharmacology|April 2, 1999
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeysJ D Jentsch, J R Taylor, D E Redmond, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
(S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitizationB A Morrow, E J Lee, J R Taylor, et al.
Neuroscience|August 1, 1994
Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systemsT J Collier, J D Elsworth, J R Taylor, et al.
Neuroscience Letters|July 11, 1986
Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineA Y Deutch, J D Elsworth, M Goldstein, et al.
Experimental Neurology|April 21, 2001
Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degenerationB Connor, D A Kozlowski, J R Unnerstall, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Neuroscience|January 1, 1989
Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regionsJ D Elsworth, A Y Deutch, D E Redmond, et al.
Life Sciences|January 1, 1991
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestionP Jatlow, J D Elsworth, C W Bradberry, et al.
Experimental Brain Research|January 11, 1991
Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controlsJ R Taylor, J D Elsworth, R H Roth, et al.
Cell Transplantation|March 1, 1997
Metabolic energy capacity of dopaminergic grafts and the implanted striatum in parkinsonian nonhuman primates as visualized with cytochrome oxidase histochemistryT J Collier, D E Redmond, R H Roth, et al.
Progress in Brain Research|January 1, 1990
Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeysJ R Taylor, J D Elsworth, R H Roth, et al.
Psychopharmacology|April 2, 1999
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeysJ D Jentsch, J R Taylor, D E Redmond, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
(S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitizationB A Morrow, E J Lee, J R Taylor, et al.
Neuroscience|August 1, 1994
Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systemsT J Collier, J D Elsworth, J R Taylor, et al.
Neuroscience Letters|July 11, 1986
Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineA Y Deutch, J D Elsworth, M Goldstein, et al.
Experimental Neurology|April 21, 2001
Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degenerationB Connor, D A Kozlowski, J R Unnerstall, et al.
Pageof 10